Pancreatitis as an adverse reaction to salicylazosulfapyridine.

Suppr

超能文献

作者信息

Block M B, Genant H K, Kirsner J B

出版信息

N Engl J Med. 1970 Feb 12;282(7):380-2. doi: 10.1056/NEJM197002122820710.

DOI:10.1056/NEJM197002122820710

PMID:4391490

Abstract

摘要

相似文献

Pancreatitis as an adverse reaction to salicylazosulfapyridine.

N Engl J Med. 1970 Feb 12;282(7):380-2. doi: 10.1056/NEJM197002122820710.

Gastroenterology. 1979 Oct;77(4 Pt 2):883-6.

Pancreatitis and pancreatic necrosis during sulfasalazine therapy.

Int Surg. 1985 Jul-Sep;70(3):271-2.

[Pancreatic complications of sulfasalazine].

Rev Hosp Clin Fac Med Sao Paulo. 1986 Mar-Apr;41(2):87-90.

Acute pancreatitis as a complication of Imuran therapy in regional enteritis.

Gastroenterology. 1972 May;62(5):1040-1.

Prevention of pancreatitis by weekly amylase assay in patients with Crohn's disease treated with azathioprine.

Am J Gastroenterol. 2000 Sep;95(9):2394-5. doi: 10.1111/j.1572-0241.2000.02347.x.

[Side effects of salicylazosulfapyridine therapy].

Dtsch Med Wochenschr. 1980 Nov 14;105(46):1596-7. doi: 10.1055/s-2008-1070919.

Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis.

Am J Gastroenterol. 1994 May;89(5):789-91.

Pancreatitis induced by disodium azodisalicylate.

Am J Gastroenterol. 1988 May;83(5):578-80.

[Pancreatitis associated with 5-aminosalicylic acid].

Dtsch Med Wochenschr. 1991 Apr 5;116(14):540-2. doi: 10.1055/s-2008-1063645.

引用本文的文献

Drug-Induced Acute Pancreatitis: An Evidence-Based Classification (Revised).

Clin Transl Gastroenterol. 2023 Aug 1;14(8):e00621. doi: 10.14309/ctg.0000000000000621.

Systematic review-pancreatic involvement in inflammatory bowel disease.

Aliment Pharmacol Ther. 2022 Jun;55(12):1478-1491. doi: 10.1111/apt.16949. Epub 2022 May 3.

Pancreatic Disorders in Patients with Inflammatory Bowel Disease.

Dig Dis Sci. 2022 Feb;67(2):423-436. doi: 10.1007/s10620-021-06899-2. Epub 2021 Feb 24.

Retrospective Matched-Cohort Analysis of Acute Pancreatitis Induced by 5-Aminosalicylic Acid-Derived Drugs.

Pancreas. 2019 Apr;48(4):488-495. doi: 10.1097/MPA.0000000000001297.

Pancreatic disorders in inflammatory bowel disease.

World J Gastrointest Pathophysiol. 2016 Aug 15;7(3):276-82. doi: 10.4291/wjgp.v7.i3.276.

Drug-induced pancreatitis : incidence, management and prevention.

Drug Saf. 2008;31(10):823-37. doi: 10.2165/00002018-200831100-00002.

Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?

World J Gastroenterol. 2006 Oct 14;12(38):6115-23. doi: 10.3748/wjg.v12.i38.6115.

Comparative tolerability of treatments for inflammatory bowel disease.

Drug Saf. 2000 Nov;23(5):429-48. doi: 10.2165/00002018-200023050-00006.

The pancreas and inflammatory bowel diseases.

Int J Pancreatol. 2000 Jun;27(3):171-9. doi: 10.1385/IJGC:27:3:171.

Acute pancreatitis secondary to 5-aminosalicylic acid therapy in a patient with ulcerative colitis.

Int J Pancreatol. 1999 Jun;25(3):217-21. doi: 10.1007/BF02925970.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Pancreatitis as an adverse reaction to salicylazosulfapyridine.

N Engl J Med. 1970 Feb 12;282(7):380-2. doi: 10.1056/NEJM197002122820710.

Gastroenterology. 1979 Oct;77(4 Pt 2):883-6.

Pancreatitis and pancreatic necrosis during sulfasalazine therapy.

Int Surg. 1985 Jul-Sep;70(3):271-2.

[Pancreatic complications of sulfasalazine].

Rev Hosp Clin Fac Med Sao Paulo. 1986 Mar-Apr;41(2):87-90.

Acute pancreatitis as a complication of Imuran therapy in regional enteritis.

Gastroenterology. 1972 May;62(5):1040-1.

Prevention of pancreatitis by weekly amylase assay in patients with Crohn's disease treated with azathioprine.

Am J Gastroenterol. 2000 Sep;95(9):2394-5. doi: 10.1111/j.1572-0241.2000.02347.x.

[Side effects of salicylazosulfapyridine therapy].

Dtsch Med Wochenschr. 1980 Nov 14;105(46):1596-7. doi: 10.1055/s-2008-1070919.

Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis.

Am J Gastroenterol. 1994 May;89(5):789-91.

Pancreatitis induced by disodium azodisalicylate.

Am J Gastroenterol. 1988 May;83(5):578-80.

[Pancreatitis associated with 5-aminosalicylic acid].

Dtsch Med Wochenschr. 1991 Apr 5;116(14):540-2. doi: 10.1055/s-2008-1063645.

引用本文的文献

Drug-Induced Acute Pancreatitis: An Evidence-Based Classification (Revised).

Clin Transl Gastroenterol. 2023 Aug 1;14(8):e00621. doi: 10.14309/ctg.0000000000000621.

Systematic review-pancreatic involvement in inflammatory bowel disease.

Aliment Pharmacol Ther. 2022 Jun;55(12):1478-1491. doi: 10.1111/apt.16949. Epub 2022 May 3.

Pancreatic Disorders in Patients with Inflammatory Bowel Disease.

Dig Dis Sci. 2022 Feb;67(2):423-436. doi: 10.1007/s10620-021-06899-2. Epub 2021 Feb 24.

Retrospective Matched-Cohort Analysis of Acute Pancreatitis Induced by 5-Aminosalicylic Acid-Derived Drugs.

Pancreas. 2019 Apr;48(4):488-495. doi: 10.1097/MPA.0000000000001297.

Pancreatic disorders in inflammatory bowel disease.

World J Gastrointest Pathophysiol. 2016 Aug 15;7(3):276-82. doi: 10.4291/wjgp.v7.i3.276.

Drug-induced pancreatitis : incidence, management and prevention.

Drug Saf. 2008;31(10):823-37. doi: 10.2165/00002018-200831100-00002.

Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?

World J Gastroenterol. 2006 Oct 14;12(38):6115-23. doi: 10.3748/wjg.v12.i38.6115.

Comparative tolerability of treatments for inflammatory bowel disease.

Drug Saf. 2000 Nov;23(5):429-48. doi: 10.2165/00002018-200023050-00006.

The pancreas and inflammatory bowel diseases.

Int J Pancreatol. 2000 Jun;27(3):171-9. doi: 10.1385/IJGC:27:3:171.

Acute pancreatitis secondary to 5-aminosalicylic acid therapy in a patient with ulcerative colitis.

Int J Pancreatol. 1999 Jun;25(3):217-21. doi: 10.1007/BF02925970.